Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
Masashi NishimuraSatoshi SugawaShinichiro OtaEtsuko SuematsuMasahiro ShinodaMasaharu ShinkaiPublished in: PloS one (2022)
For the prevention of nosocomial infection of SARS-CoV-2, identification of silent infection is essential. For the detection of ongoing infection, periodical screening with IgG (RBD) in addition to PCR would be an effective measure. For the surveillance of morbidity in the population, on the other hand, IgG (N)0.2 could be the most reliable indicator among the three serological tests.